Skip to main content
. 2020 Jul 2;11:581. doi: 10.3389/fpsyt.2020.00581

Table 1.

Socio-demographic and clinical data at T1 and T2.

Characteristic Group Comparison
MA (n = 30) HC (n = 24) Test value p
Socio-demographic data
 Age (years) 29.0 ± 6.8 28.8 ± 5.6 0.121 a .904
 Sex (females) 36.7 (11) 33.3 (8) 0.065 b .799
 Partnership 43.3 (13) 62.5 (15) 1.962 b .161
 Migration 2.5 (1) 7.5 (3) 1.634 b .201
 Children 63.3 (19) 50.0 (12) −1.335 c .182
 Education* 76.7 (23) 70.8 (17) 0.236 b .627
 Unemployment 70.0 (21) 20.8 (5) 13.900 b .001
Clinical data
 Age of first MA use (years) 19.2 ± 5.2 N/A N/A N/A
 MA abuse duration (years) 7.0 ± 4.3 N/A N/A N/A
 Abstinence (days) 19.5 ± 50.3 N/A N/A N/A
 Psychiatric comorbidities 53.3 (16) N/A N/A N/A
 Medication 16.7 (5) N/A N/A N/A
 FH+ 43.3 (13) N/A N/A N/A

Descriptive statistics (mean ± SD or % (N)) and results of group differences. MA, methamphetamine patients; HC, healthy controls; FH+, positive family history for psychiatric disorders according to first-degree relatives.

*secondary school or lower.

a

t (paired t-test).

b

Pearson chi-square (exact chi-square test).

c

Z (Wilcoxon matched pairs rank sum test).

In bold: significant at p < 0.05.